Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

CompletedOBSERVATIONAL
Enrollment

1,695

Participants

Timeline

Start Date

October 11, 2011

Primary Completion Date

April 19, 2013

Study Completion Date

April 19, 2013

Conditions
Gastric CancerGastroesophageal Junction Cancer
Trial Locations (14)

31116

Dankook University Hospital, Chungcheongnam-do

41931

Keimyung University Dongsan Medical Center, Daegu

42472

Daegu Catholic University Medical Center, Daegu

46033

Dongnam Inst.of Radiological & Medical Sciences, Busan

47392

Inje University Busan Paik Hospital, Busan

48108

Inje university Haeundae Paik Hospital, Busan

49267

Kosin University Gospel Hospital, Busan

50612

Pusan National University Yangsan Hospital, Gyeongsangnam-do

52727

Gyeongsang National University Hospital, Gyeongsangnam-do

61453

Chosun University Hospital, Gwangju

602-739

Pusan University Hospital, Busan

Unknown

Samsung Changwon Hospital, Changwon

705-717

Yeungnam Univ. Hospital, Daegu

561-712

Chonbuk National Uni Hospital, Jeollabuk-do

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02538562 - Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea | Biotech Hunter | Biotech Hunter